Nearly 700 million people still live without electricity worldwide

Senegal COVID-19 Response Project

Abstract*

The Senegal COVID-19 Response Project (P173838) was initiated to prevent, detect, and respond to the COVID-19 pandemic while strengthening Senegal's national public health preparedness. Approved on April 2, 2020, and made effective on April 6, 2020, the project will close on December 31, 2025. Two rounds of Additional Financing (AF) have expanded the project’s scope. The first, approved in 2021, increased the project’s funding by USD 134 million to... Show More

Development Objective

The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Senegal

Key Details

Project Details

Project ID
P173838
Status
Active
Team Leader
Christophe Lemiere , Aida Gadiaga
Borrower 2
Ministry of Finances and Budget

Country
Senegal
Disclosure Date
March 26, 2020
Approval Date
(as of board presentation)
April 2, 2020
Effective Date
April 6, 2020

Total Project Cost 1
US$ 20.00 million
Implementing Agency
Ministry of Health and Social Action
Region
Western and Central Africa
Fiscal Year 3
2020

Commitment Amount
US$ 169.00 million
Environmental Category
N/A
Environmental and Social Risk
Substantial
Closing Date
December 31, 2025

Consultant Services required
No
Last Stage Reached
BANK APPROVED
Last Update Date
April 8, 2024

Associated Projects
P181056
P175992

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Environment and Natural Resource Management

FY17 - Climate change0%
- FY17 - Adaptation0%

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Gender31%
FY17 - Health Systems and Policies83%
- FY17 - Health Finance83%
- FY17 - Health System Strengthening79%

FY17 - Social Development and Protection

FY17 - Social Inclusion11%
- FY17 - Participation and Civic Engagement11%
FY17 - Social Protection25%
- FY17 - Social Safety Nets25%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Credit	67.00
Trust Funds	15.00
IDA Grant	87.00

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	154.00
IBRD + IDA Commitment	154.00

Lending Instrument
Grant Amount	15.00
Total Project Cost**	20.00

Summary Status of World Bank Financing (US$ Millions) as of September 30, 2025

No data available.

Detailed Financial Activity as of September 30, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Oct 5, 2023	IDA-69640	Loan Disb	45,236.30
Nov 14, 2023	IDA-69640	Loan Disb	745,941.06
Apr 25, 2024	IDA-69640	Int Charges	104,669.03
Apr 25, 2024	IDA-69640	Int Charges	104,669.03
Apr 25, 2024	IDA-69640	Int Charges	136.72
Apr 25, 2024	IDA-69640	Int Charges	136.72
Apr 19, 2024	IDA-69640	Loan Disb	173,063.34
Jul 13, 2023	IDA-69640	Loan Disb	14,019.34
Oct 15, 2023	IDA-65990	Int Charges	12,030.92
Oct 15, 2023	IDA-65990	Int Charges	12,030.92
Jun 5, 2023	IDA-69640	Loan Disb	27,517.46
Jun 8, 2023	IDA-69640	Loan Disb	203,833.16
Apr 15, 2023	IDA-69640	Int Charges	264.56
Apr 15, 2023	IDA-69640	Int Charges	264.56
Apr 15, 2023	IDA-69640	Int Charges	34,668.05
Apr 15, 2023	IDA-69640	Int Charges	34,668.05
Apr 15, 2023	IDA-65990	Int Charges	75,470.55
Apr 15, 2023	IDA-65990	Int Charges	75,470.55
Apr 13, 2023	IDA-69640	Loan Disb	71,101.85
Apr 15, 2023	IDA-69640	Int Charges	43,877.11
Apr 15, 2023	IDA-69640	Int Charges	43,877.11
Dec 7, 2022	IDA-69640	Loan Disb	66,423.74
Sep 5, 2023	IDA-69640	Loan Disb	23,875.16
May 8, 2023	IDA-69640	Loan Disb	5,562,614.50
Jan 23, 2023	IDA-69640	Loan Disb	433,466.75
Oct 15, 2021	IDA-65990	Int Charges	710.98
Oct 15, 2021	IDA-65990	Int Charges	710.98
Oct 15, 2021	IDA-65990	Int Charges	74,799.96
Oct 15, 2021	IDA-65990	Int Charges	74,799.96
Mar 25, 2021	IDA-65990	Loan Disb	4,277.46
Jul 2, 2021	IDA-65990	Loan Disb	1,213,413.80
Apr 26, 2021	IDA-65990	Loan Disb	41,480.37
Apr 15, 2021	IDA-65990	Int Charges	56,340.10
Apr 15, 2021	IDA-65990	Int Charges	56,340.10
Apr 21, 2020	IDA-65990	Loan Disb	2,311,965.50
May 13, 2020	IDA-65990	Loan Disb	842,602.44
May 29, 2020	IDA-65990	Loan Disb	1,495,823.90
Jun 17, 2020	IDA-65990	Loan Disb	684,847.20
May 18, 2020	IDA-65990	Loan Disb	972,825.44
May 15, 2020	IDA-65990	Loan Disb	838,221.56
Jun 11, 2020	IDA-65990	Loan Disb	813,263.94
Nov 2, 2020	IDA-65990	Loan Disb	183,174.77
Nov 2, 2020	IDA-65990	Loan Disb	152,474.84
Oct 16, 2020	IDA-65990	Int Charges	30,020.93
Oct 16, 2020	IDA-65990	Int Charges	30,020.93
Jun 16, 2021	IDA-65990	Loan Disb	665,035.44
Dec 18, 2020	IDA-65990	Loan Disb	1,647,146.50
Nov 24, 2020	IDA-65990	Loan Disb	1,601,693.40
Nov 12, 2020	IDA-65990	Loan Disb	1,373,891.80
Oct 5, 2022	IDA-69640	Loan Disb	371,572.25
Dec 7, 2022	IDA-69640	Loan Disb	57,736.57
Dec 8, 2022	IDA-69640	Loan Disb	462,887.53
Oct 7, 2022	IDA-69640	Loan Disb	43,317.97
Nov 4, 2022	IDA-69640	Loan Disb	41,643.39
Nov 4, 2022	IDA-69640	Loan Disb	66,963.08
Oct 15, 2022	IDA-69640	Int Charges	49,185.11
Oct 15, 2022	IDA-69640	Int Charges	49,185.11
Apr 27, 2022	IDA-65990	Loan Disb	3,841.52
Apr 27, 2022	IDA-65990	Loan Disb	3,841.53
Oct 12, 2022	IDA-69640	Loan Disb	1,521,374.60
Oct 12, 2022	IDA-69640	Loan Disb	18,381.56
Oct 12, 2022	IDA-69640	Loan Disb	215,946.67
Oct 12, 2022	IDA-69640	Loan Disb	636,126.60
Oct 18, 2022	IDA-69640	Loan Disb	159,964.90
Oct 15, 2021	IDA-65990	Loan Disb	119,130.09
Oct 13, 2021	IDA-69640	Loan Disb	5,001,649.00
Sep 24, 2021	IDA-69640	Loan Disb	10,733,935.00
Apr 15, 2022	IDA-69640	Int Charges	4,520.38
Apr 15, 2022	IDA-69640	Int Charges	4,520.38
Apr 15, 2022	IDA-69640	Int Charges	54,611.39
Apr 15, 2022	IDA-69640	Int Charges	54,611.39
May 16, 2022	IDA-65990	Loan Disb	3,400.66
Apr 15, 2022	IDA-65990	Int Charges	108.09
Apr 15, 2022	IDA-65990	Int Charges	108.09
Apr 15, 2022	IDA-65990	Int Charges	73,617.12
Apr 15, 2022	IDA-65990	Int Charges	73,617.12
Sep 21, 2020	IDA-65990	Loan Disb	167,916.44
Jul 31, 2020	IDA-65990	Loan Disb	969,327.50
Oct 18, 2022	IDA-69640	Loan Disb	710,150.70
Oct 15, 2022	IDA-65990	Int Charges	97.35
Oct 15, 2022	IDA-65990	Int Charges	97.35
Oct 15, 2022	IDA-65990	Int Charges	66,434.29
Oct 15, 2022	IDA-65990	Int Charges	66,434.29
Dec 21, 2022	IDA-69640	Loan Disb	1,741,835.60
Jan 25, 2024	IDA-69640	Loan Disb	93,161.27
Jun 6, 2024	IDA-69640	Loan Disb	249,059.80
Jul 22, 2024	IDA-69640	Loan Disb	342,919.78
Apr 26, 2024	IDA-65990	Int Charges	73,215.00
Apr 26, 2024	IDA-65990	Int Charges	73,215.00
Jul 22, 2024	IDA-69640	Loan Disb	108,194.79
May 3, 2024	IDA-69640	Loan Disb	432,499.12
Nov 30, 2023	IDA-69640	Loan Disb	87,629.93
Oct 15, 2023	IDA-69640	Int Charges	2.83
Oct 15, 2023	IDA-69640	Int Charges	2.83
Oct 15, 2023	IDA-69640	Int Charges	96,785.94
Oct 15, 2023	IDA-69640	Int Charges	96,785.94
Oct 15, 2023	IDA-65990	Int Charges	59,750.90
Oct 15, 2023	IDA-65990	Int Charges	59,750.90
Dec 27, 2021	IDA-D8890	Loan Disb	1,178,335.20
Dec 15, 2021	IDA-D8890	Loan Disb	2,037,785.60
Dec 15, 2021	IDA-D8890	Loan Disb	2,204,496.00
Dec 15, 2021	IDA-D8890	Loan Disb	456,782.34
Dec 15, 2021	IDA-D8890	Loan Disb	16,803,360.00
Jun 2, 2021	IDA-69640	Loan Commitment	67,000,000.00
Jun 2, 2021	IDA-D8890	Loan Commitment	67,000,000.00
Apr 2, 2020	IDA-65990	Loan Commitment	20,000,000.00
Jan 5, 2024	IDA-D8890	Loan Disb	-16,803,360.00
Jul 31, 2020	IDA-65990	Loan Disb	1,378,418.80
Apr 15, 2021	IDA-65990	Int Charges	85.21
Apr 15, 2021	IDA-65990	Int Charges	85.21
Apr 7, 2021	IDA-65990	Loan Disb	487,375.50
Apr 7, 2021	IDA-65990	Loan Disb	910,312.70
May 21, 2021	IDA-65990	Loan Disb	670,603.06
Jun 8, 2021	IDA-65990	Loan Disb	596,601.70
Mar 18, 2021	IDA-65990	Loan Disb	84,537.20
Mar 18, 2021	IDA-65990	Loan Disb	4,322.90
Mar 18, 2021	IDA-65990	Loan Disb	354,979.28
Mar 18, 2021	IDA-65990	Loan Disb	436,862.30

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Procurement	Moderately Satisfactory	2025-06-02
Overall Implementation Progress (IP)	Moderately Unsatisfactory	2025-06-02
Progress towards achievement of PDO	Moderately Satisfactory	2025-06-02
Project Management	Moderately Unsatisfactory	2025-06-02
Financial Management	Moderately Satisfactory	2025-06-02
Monitoring and Evaluation	Moderately Satisfactory	2025-06-02

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Suspected cases of COVID-19 cases reported and investigated per approved protocol Value 0.00 1028260.00 600000.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Suspected cases that test positive Value 0.00 88955.00 50000.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Health staff trained in COVID-19 prevention, testing and care per MoHSA-approved protocols Value 1518.00 6610.00 2500.00
Date November 17, 2020 February 27, 2024 December 31, 2025
Comment
District health centers/hospitals with personal protective equipment and infection control products and supplies Value 0.00 84.00 90.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Percentage of population vaccinated Value 0.00 17.00 55.00
Date February 1, 2021 February 27, 2024 December 31, 2025
Comment
Percentage of population vaccinated, which is included in the priority population targets defined in national plan Value 0.00 4.77 20.00
Date February 1, 2021 February 27, 2024 December 31, 2025
Comment
Females vaccinated Value 0.00 51.44 40.00
Date February 1, 2021 February 27, 2024 December 31, 2025
Comment
Female healthcare workers vaccinated Value 0.00 54.41 60.00
Date February 1, 2021 February 27, 2024 December 31, 2025
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Healthcare workers and community-based nurses trained on COVID-19 prevention, control and contact tracing Value 0.00 6335.00 2000.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Assessment conducted to identify behavioral and socio-cultural risk factors for COVID-19 covering all the regions Value No Yes Yes
Date March 19, 2020 February 27, 2024 June 30, 2021
Comment
Establishment of joint M&E systems supporting the One Health approach and epidemic preparedness and response Value No Yes Yes
Date March 19, 2020 February 27, 2024 June 30, 2021
Comment
People reached through hygiene promotion activities Value 0.00 540.00 1000.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Meetings held by the platform Value 0.00 92.00 125.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Healthcare facilities that received protective equipment and hygiene materials Value 0.00 116.00 119.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Community health workers trained on community-based disease surveillance Value 0.00 0.00 2000.00
Date September 18, 2023 February 27, 2024 December 31, 2025
Comment
Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents per MOHSA guidelines Value 0.00 9.00 7.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Implementation of the third and fourth phases of the rapid surveillance system for the continuity of EHS Value No No Yes
Date April 4, 2023 February 27, 2024 December 31, 2025
Comment
Patients that are satisfied with the treatment of COVID-19 received Value 0.00 71.53 70.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Community actors trained Value 0.00 0.00 500.00
Date May 1, 2023 February 27, 2024 December 31, 2025
Comment

Number of healthcare facilities and warehouses provided with climate-sensitive/energy-efficient cold chain equipment to store COVID-19 vaccines	Value	0.00	2.00	50.00
	Date	February 15, 2021	February 27, 2024	December 31, 2025
	Comment

TV, radio and social media spots produced on COVID-19 Value 0.00 300.00 400.00
Date February 15, 2021 February 27, 2024 December 31, 2025
Comment

Number of national, sub-national, facility-based and mobile staff trained in COVID-19 vaccine cold chain, storage and handling	Value	0.00	0.00	300.00
	Date	February 15, 2021	February 27, 2024	December 31, 2025
	Comment

Healthcare workers and community-based nurses trained on GBV/SEA/SH Value 0.00 12.00 300.00
Date April 1, 2021 February 27, 2024 December 31, 2025
Comment
Pharmacovigilance System (PVS) adapted to detect Adverse Events Following Vaccination (AEFI) for the COVID-19 vaccine Value No Yes Yes
Date February 15, 2021 February 27, 2024 December 31, 2021
Comment
Number of AEFI cases reported Value 0.00 134.00 100.00
Date February 23, 2021 February 27, 2024 December 31, 2025
Comment
Women having 4 antenatal care visits (ANCs) Value 65.00 0.00 83.00
Date December 31, 2022 February 27, 2024 December 31, 2025
Comment
People who have received essential health, nutrition, and population (HNP) services Value 8085860.00 0.00 8817975.00
Date December 31, 2022 February 27, 2024 December 31, 2025
Comment
People who have received essential health, nutrition, and population (HNP) services - Female (RMS requirement) Value 0.00 0.00 0.00
Date
Comment
Number of children immunized Value 125137.00 0.00 275137.00
Date December 31, 2022 February 27, 2024 December 31, 2025
Comment
Number of women and children who have received basic nutrition services Value 0.00 0.00 245229.00
Date April 4, 2023 February 27, 2024 December 31, 2025
Comment
Number of deliveries attended by skilled health personnel Value 263114.00 0.00 600000.00
Date December 31, 2022 February 27, 2024 December 31, 2025
Comment
Contraceptive prevalence rate Value 25.50 0.00 36.00
Date December 31, 2022 February 27, 2024 December 31, 2025
Comment

Health facilities reporting no stock-out of tracer essential medicines and products, including COVID-19 vaccincations, at the time of the health facility supervision visit	Value	0.00	0.00	80.00
	Date	April 4, 2023	February 27, 2024	December 31, 2025
	Comment

Health personnel trained Value 0.00 0.00 2000.00
Date May 1, 2023 February 27, 2024 December 31, 2025
Comment
Females Value 0.00 0.00 1000.00
Date June 1, 2023 February 27, 2024 December 31, 2025
Comment
Continuous Value 0.00 0.00 1900.00
Date May 1, 2023 February 27, 2024 December 31, 2025
Comment
Point of entry/ border officers trained on COVID-19 prevention, control and contact tracing Value 0.00 901.00 160.00
Date March 19, 2020 February 27, 2024 December 31, 2021
Comment
Social Distancing communication strategy developed Value No Yes Yes
Date March 19, 2020 February 27, 2024 July 31, 2020
Comment
Health centers/hospitals received supervision for COVID-19 Value 0.00 99.00 80.00
Date March 19, 2020 February 27, 2024 December 31, 2025
Comment
Long-term Value 0.00 0.00 100.00
Date May 1, 2023 February 27, 2024 December 31, 2025
Comment

Suspected cases that test positive	Value	0.00	88955.00	50000.00
	Date	March 19, 2020	February 27, 2024	December 31, 2025
	Comment

Health staff trained in COVID-19 prevention, testing and care per MoHSA-approved protocols	Value	1518.00	6610.00	2500.00
	Date	November 17, 2020	February 27, 2024	December 31, 2025
	Comment

Percentage of population vaccinated	Value	0.00	17.00	55.00
	Date	February 1, 2021	February 27, 2024	December 31, 2025
	Comment

Females vaccinated	Value	0.00	51.44	40.00
	Date	February 1, 2021	February 27, 2024	December 31, 2025
	Comment

Female healthcare workers vaccinated	Value	0.00	54.41	60.00
	Date	February 1, 2021	February 27, 2024	December 31, 2025
	Comment

Meetings held by the platform	Value	0.00	92.00	125.00
	Date	March 19, 2020	February 27, 2024	December 31, 2025
	Comment

Community actors trained	Value	0.00	0.00	500.00
	Date	May 1, 2023	February 27, 2024	December 31, 2025
	Comment

Number of AEFI cases reported	Value	0.00	134.00	100.00
	Date	February 23, 2021	February 27, 2024	December 31, 2025
	Comment

Women having 4 antenatal care visits (ANCs)	Value	65.00	0.00	83.00
	Date	December 31, 2022	February 27, 2024	December 31, 2025
	Comment

People who have received essential health, nutrition, and population (HNP) services	Value	8085860.00	0.00	8817975.00
	Date	December 31, 2022	February 27, 2024	December 31, 2025
	Comment

Number of children immunized	Value	125137.00	0.00	275137.00
	Date	December 31, 2022	February 27, 2024	December 31, 2025
	Comment

Number of deliveries attended by skilled health personnel	Value	263114.00	0.00	600000.00
	Date	December 31, 2022	February 27, 2024	December 31, 2025
	Comment

Contraceptive prevalence rate	Value	25.50	0.00	36.00
	Date	December 31, 2022	February 27, 2024	December 31, 2025
	Comment

Health personnel trained	Value	0.00	0.00	2000.00
	Date	May 1, 2023	February 27, 2024	December 31, 2025
	Comment

Females	Value	0.00	0.00	1000.00
	Date	June 1, 2023	February 27, 2024	December 31, 2025
	Comment

Continuous	Value	0.00	0.00	1900.00
	Date	May 1, 2023	February 27, 2024	December 31, 2025
	Comment

Long-term	Value	0.00	0.00	100.00
	Date	May 1, 2023	February 27, 2024	December 31, 2025
	Comment

Senegal COVID-19 Response Project

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of September 30, 2025

Detailed Financial Activity as of September 30, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS